| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | BIOTECNOLOGÍA | 28,05% | 56,09% | 85,80% | 217,10% |
| A&P LIFESCIENCE FUND, FI B | BIOTECNOLOGÍA | 28,03% | 10,82% | · | · |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | BIOTECNOLOGÍA | 27,99% | 55,87% | 85,59% | 217,40% |
| FIDELITY FUNDS-ITALY E-ACC-EUR | RV EURO | 27,98% | 70,48% | 106,40% | 94,41% |
| PRIVILEDGE - ALPHA JAPAN (EUR) M CAP SYST. HDG | RVI JAPÓN | 27,98% | 93,46% | 133,53% | 206,78% |
| ERSTE STOCK EUROPE EMERGING CZK R01 KEST-EXEMPT CAP | RVI EMERGENTES EUROPA | 27,97% | 86,12% | · | 5,85% |
| AXA WORLD FUNDS-ITALY EQUITY A CAP EUR | RV EURO | 27,92% | 48,26% | 62,01% | 63,34% |
| COBAS SELECCION, FI D | RVI EUROPA VALOR | 27,89% | 60,60% | · | · |
| NINETY ONE GSF ASIAN EQUITY FUND A ACC EUR HEDGED | RVI ASIA EX-JAPÓN | 27,89% | 52,20% | 15,85% | · |
| BANKINTER BOLSA ESPAÑA OBJETIVO 2027, FI | RF EURO LARGO PLAZO | 27,87% | 52,25% | 46,59% | 51,25% |
